The integration of Artificial Intelligence (AI) is revolutionizing the healthcare industry, particularly in patient support programs (PSPs) and marketing strategies. AI technology's predictive power allows for tailored medical interventions and personalized patient support, moving away from the traditional persona-based approaches. This personalized attention boosts patient engagement and improves adherence to prescribed therapies, significantly enhancing health…
Artificial Intelligence (AI) is a powerful tool transforming the landscape of the healthcare industry, in particular, pharmaceuticals. However, for pharmaceutical companies to reap the benefits of AI requires strategic integration and proper navigation. Five key questions typically arise when incorporating AI into pharmaceutical practices.
Firstly, companies need to define their aim for using AI, this…
This article seeks to debunk prevalent misconceptions about artificial intelligence (AI) strategy in healthcare, emphasizing its potential transformative ability. Various sectors can utilize AI to facilitate scientific breakthroughs, transform disease diagnosis and management, expedite drug development, and foster health equity initiatives. However, AI implementation calls for a clear comprehension of the difference between the capabilities…
AllazoHealth is revolutionizing healthcare management and improving patient outcomes with its AI-powered platform, personalized to support patients in therapeutic areas including asthma, cardiovascular health, diabetes, and behavioral health. AI is used to identify high-risk patients, streamline medication initiation, and aid with medication adherence, thereby improving patients' health results and reducing healthcare costs.
Asthma management is…
More than 30 percent of patients fail to fill their prescription medications, which partly results from persona-based marketing and patient support programs (PSPs) often falling short. This issue is particularly alarming given the growing elderly population, escalating chronic illnesses, and the mounting pressure on healthcare resources. Ensuring medication adherence has become a pressing issue owing…
As we advance through 2024, artificial intelligence (AI) continues to evolve rapidly, revealing a wealth of transformative possibilities for the pharmaceutical industry. In this article, we examine the top 5 AI predictions for 2024 that are poised to reshape the landscape of drug manufacturing and guide the future of innovation and impact.
Firstly, precision medicine is…
Scientist and entrepreneur, Prof Gary Marcus, recently shared his views on the possible roadblocks in generative AI's (Artificial Intelligence) future in a blog post, raising questions about its potential usefulness. He points to numerous serious and unresolved issues at the core of generative AI, including their tendency to hallucinate or create false information, and their…
AI in Healthcare: A Glimpse into the Future through the Eyes of Syntho's CEO
In anticipation of the Intelligent Health conference scheduled for 13th-14th September, 2023, in Basel, Switzerland, we had an enlightening chat with Wim Kees Janssen, Co-Founder & CEO of Syntho regarding his views on the future of AI in health care.
Since its inception,…
With Intelligent Health approaching (13-14 September 2023, Basel, Switzerland), Mostafa Ajallooeian, Engagement Director, Senior Data Scientist at Unit8 SA, shares his predictions on the future of Artificial Intelligence (AI) in healthcare, especially concerning the use of Generative AI (GenAI) and Large Language Models (LLMs).
On the subject of GenAI and LLMs having a transformative effect on…
Helge Buess, the Associate Director Population Health of the Novartis Foundation, recently shared his insight on the future of Artificial Intelligence (AI) in healthcare, in the lead-up to Intelligent Health, due to be held in Basel, Switzerland, from 13th-14th September 2023. Topics discussed include the potential significant impact of Generative AI and the usage of…
In a recent interview ahead of the Intelligent Health conference which is slated for 13-14 September 2023 in Basel, Switzerland, Frank Dannacher’s, who is the Director, Lead AI & Data for Life Science and Healthcare at Deloitte Switzerland, shared his insights on the future of Artificial Intelligence (AI) in the healthcare landscape. One of the…